|
WO2016115360A1
|
|
C-myc ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
WO2015106294A1
|
|
Bivalent bcr-abl tyrosine kinase ligands, and methods of using same
|
|
WO2015106292A1
|
|
Bcr-abl tyrosine-kinase ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
WO2015081284A1
|
|
Bivalent bromodomain ligands, and methods of using same
|
|
WO2015081280A1
|
|
Bromodomain ligands capable of dimerizing in an aqueous solution
|
|
US2015087043A1
|
|
Monomers capable of multimerizing in an aqueous solution that employ bioorthogonal chemistries, and methods of using same
|
|
US2015080570A1
|
|
Alpha,beta-unsaturated monomers capable of multimerization in an aqueous solution, and methods of using same
|
|
WO2013033268A2
|
|
Bivalent bromodomain ligands, and methods of using same
|
|
WO2013033269A1
|
|
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
WO2012139134A2
|
|
Methods of modulating oncogenic fusion proteins
|
|
AU2010303946A1
|
|
Coferons and methods of making and using them
|
